ADAR1 Capital Management »

Schrodinger shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Schrodinger (SDGR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Schrodinger

Tip: Access up to 7 years of quarterly data

All positions including Schrodinger held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Schrodinger by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 64k 27.00
2023-12-31 $72k 2.0k 35.80

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Schrodinger

BlackRock
Bill & Melinda Gates Foundation Trust
Vanguard Group
Baillie Gifford & Co
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Credit Suisse
Morgan Stanley
Nikko Asset Management Americas
Geode Capital Management
Lazard Asset Management
Schonfeld Strategic Advisors
Dimensional Fund Advisors
Parkman Healthcare Partners
Rubric Capital Management

View all funds holding Schrodinger